Medifast, Inc.
MED
$13.75
-$0.34-2.41%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -86.73% | -95.13% | -126.93% | -79.19% | -77.24% |
| Total Depreciation and Amortization | -5.01% | -275.73% | -8.94% | 9.65% | 13.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -138.98% | 590.73% | 347.38% | -72.36% | 43.35% |
| Change in Net Operating Assets | 47.42% | -80.34% | -118.85% | -127.60% | -161.79% |
| Cash from Operations | -147.02% | -69.69% | -69.71% | -88.63% | -79.66% |
| Capital Expenditure | -141.54% | 17.16% | -11.12% | 12.96% | 89.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -75.23% | 99.12% | -- | -- | -- |
| Cash from Investing | -81.07% | 96.16% | -45.18% | -31.21% | -18.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -- | -65.71% | -- |
| Repurchase of Common Stock | 90.00% | 98.18% | -700.00% | 88.05% | 99.84% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 100.00% | 99.99% | 99.98% | 96.29% | -0.31% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 99.99% | 99.98% | 99.89% | 94.24% | 26.41% |
| Foreign Exchange rate Adjustments | 100.00% | -84.62% | -68.89% | 66.67% | 45.73% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -33.14% | 121.04% | -55.43% | -91.59% | -201.84% |
